Key Laboratory of Marine Drugs of Ministry of Education, Shandong Provincial Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China.
Key Laboratory of Marine Drugs of Ministry of Education, Shandong Provincial Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China; Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao, 266237, China.
Curr Opin Biotechnol. 2021 Jun;69:191-198. doi: 10.1016/j.copbio.2020.12.023. Epub 2021 Jan 30.
Carbohydrates, one of the most abundant and widespread biomolecules in nature, play indispensable roles in diverse biological functions, and represent a treasure trove of untapped potential for pharmaceutical applications. Here, we provide a brief overview of carbohydrate-based drug development (CBDD) over the past two decades. More importantly, advanced techniques and methodologies related to CBDD are emerging, including enzymatic synthesis, metabolic engineering, site-specific glycoconjugation, carbohydrate libraries and microarrays as well as carbohydrate-gut microbiome evaluation. These technologies have dramatically accelerated the speed of CBDD. The recently approved drugs and emerging techniques summarized herein will inspire new sights into potential opportunities to discover novel carbohydrate drugs.
碳水化合物是自然界中最丰富和广泛存在的生物分子之一,在各种生物功能中发挥着不可或缺的作用,并且为药物应用提供了尚未开发的潜在宝库。在这里,我们简要概述了过去二十年中基于碳水化合物的药物开发 (CBDD)。更重要的是,与 CBDD 相关的先进技术和方法正在出现,包括酶合成、代谢工程、定点糖缀合、碳水化合物文库和微阵列以及碳水化合物-肠道微生物组评估。这些技术极大地加快了 CBDD 的速度。本文总结的最近批准的药物和新兴技术将激发新的视角,为发现新型碳水化合物药物提供潜在机会。